Global Transfer Membrane Market 2018-2023 - Increasing R&D Spending By Pharmaceutical and Biotechnology Companies

The global transfer membrane market is expected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period. 

Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of transfer membrane market.

The report analyzes the global transfer membrane market by type, transfer method, application, end user, and region.

On the basis of type, the transfer membrane market is divided into nylon membranes, nitrocellulose membranes, and PVDF membranes. In 2018, PVDF membranes are expected to command for the major share of the transfer membrane market. This can be attributed to the advantages of PVDF membranes over its counterparts, such as better protein retention, strength, chemical compatibility, and wide applications in western blotting.

Based on end user, the transfer membrane market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. Among these, the academic and research institutes segment is expected to account for the largest share of the transfer membrane market in 2018, owing it to the rising financial support from private as well as government bodies for life science research in various nations.

This report covers the transfer membrane market data across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the global transfer membrane market in 2018, followed by Europe. The large share in the North American region is mainly attributed to the presence of leading transfer membrane manufacturers in the region, availability of government and private financial support for life science research, and high target disease prevalence in the region. Factors such as rising proteomic research and growing scale of life science projects funded by government and private bodies, are driving the growth of the Asia Pacific transfer membrane market.

The the availability of alternative technologies and the need of skilled professionals are expected to restrain the growth of the transfer membrane market in the forecast period.

As of 2017, Merck KGaA (US) dominates the global transfer membrane market through its broad product portfolio, strong geographical presence, and wide customer base across the globe. Thermo Fisher Scientific (US) held the second leadership position in the global transfer membrane market.

Key Topics Covered: 

1 Introduction

2 Research Methodology

3 Executive Summary 

4 Premium Insights 
4.1 Transfer Membrane: Market Overview
4.2 Transfer Membrane Market, By Type (2018 vs 2023)
4.3 Transfer Membrane Market, By Transfer Method (2018 vs 2023)
4.4 Transfer Membrane Market, By Application (2018 vs 2023)
4.5 Geographic Analysis: Transfer Membrane Market, By End User, 2018 vs 2023 (USD Million)

5 Market Overview 
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Public and Private Funding for Life Science Research
5.2.1.2 High Prevalence of Target Diseases Across the Globe
5.2.1.3 Increasing R&D Spending By Pharmaceutical and Biotechnology Companies
5.2.2 Restraints
5.2.2.1 Availability of Alternative Technologies
5.2.2.2 Need of Skilled Professionals
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Research and Development Activities in the Field of Proteomics
5.2.4 Challenges
5.2.4.1 Durability and Sensitivity of Transfer Membranes

6 Transfer Membrane Market, By Type 
6.1 Introduction
6.2 PVDF Transfer Membranes
6.3 Nitrocellulose Transfer Membranes
6.4 Nylon Transfer Membranes

7 Transfer Membrane Market, By Transfer Method 
7.1 Introduction
7.2 Tank Electrotransfer
7.3 Semi-Dry Electrotransfer
7.4 Dry Electrotransfer
7.5 Other Transfer Methods

8 Transfer Membrane Market, By Application 
8.1 Introduction
8.2 Northern Blotting
8.3 Southern Blotting
8.4 Western Blotting
8.5 Protein Sequencing and Amino Acid Analysis
8.6 Other Applications

9 Transfer Membrane Market, By End User 
9.1 Introduction
9.2 Academic and Research Institutes
9.3 Pharmaceutical and Biotechnology Companies
9.4 Diagnostic Laboratories
9.5 Other End Users

10 Transfer Membrane Market, By Region 
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 Rest of Asia Pacific
10.5 Rest of the World (RoW)
10.5.1 Middle East and Africa
10.5.2 Latin America

11 Competitive Landscape 
11.1 Transfer Membrane Market Ranking Analysis, By Key Player, 2017

12 Company Profile 
12.1 Abcam
12.2 Advansta
12.3 Atto Corporation
12.4 Axiva Sichem Biotech
12.5 Azure Biosystems
12.6 Bio-Rad Laboratories
12.7 Carl Roth
12.8 GE Healthcare
12.9 GVS
12.10 Macherey-Nagel
12.11 Merck KGaA
12.12 Pall Corporation (Subsidiary of Danaher Corporation)
12.13 Perkinelmer
12.14 Santa Cruz Biotechnology
12.15 Thermo Fisher Scientific

  • Abcam
  • Advansta
  • Atto Corporation
  • Axiva Sichem Biotech
  • Azure Biosystems
  • Bio-Rad Laboratories
  • Carl Roth
  • GE Healthcare
  • GVS
  • Macherey-Nagel
  • Merck KGaA
  • Pall Corporation (Subsidiary of Danaher Corporation)
  • Perkinelmer
  • Santa Cruz Biotechnology
  • Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/research/m55cpn/global_transfer?w=5


Media Contact:

Research and Markets 
Laura Wood, Senior Manager 
press@researchandmarkets.com 

For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630 
For GMT Office Hours Call +353-1-416-8900 

U.S. Fax: 646-607-1907 
Fax (outside U.S.): +353-1-481-1716

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Research and Markets

Our purpose is simple - to enable intelligent decision making.

15 years ago we began selling market research reports. Today we are the world's largest market research store - connecting global information professionals with market insights and analysis from 1,700 research teams based across 81 countries.

We are proud to count over 450 of the Fortune 500 as our clients.